Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 09-10-2014 | Practice Area: | Corporate and M&A |
| Deal Title: | GlaxoSmithKline Japan Strategic Collaboration with the Aspen Group | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Slaughter and May is advising GlaxoSmithKline (GSK) on its strategic collaboration with the Aspen Group (Aspen) in Japan, as announced on 9 October 2014.
The transaction involves GSK and Aspen contributing certain branded products and capital to the collaboration. GSK will also contribute to the collaboration the right to commercialise authorised generic versions of a number of its products once the exclusivity period for those products has expired.
Corporate and Commercial: Richard Smith (partner), Jeremy Chew (associate), Claire Jackson (associate); Intellectual Property: Susie Middlemiss (partner), Sarah Mateen (associate); Tax: Dominic Robertson (partner); Competition: Jordan Ellison (partner), Stephen Heagney (associate).
|
||
| Financial Center: | London | Value: | 0.00-0.00 |
| Advised Party: | Joint Venture Party | Law Firm | Slaughter and May |
| JV Party Jurisdiction | United Kingdom | JV Party Jurisdiction | United Kingdom |
| Classification: |
Joint Ventures Continuing Business Partnership |
Lawyer | Richard Smith |
